Trump administration proposes Medicare pilots to lower drug prices

Taking stock of the drug industry, from the lab to the medicine chest

December 22, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Eric Thayer/Getty Images STAT+ | Trump administration proposes Medicare pilots to lower drug prices on par with peer countries The Medicare experiments would lower the prices of some prescription drugs to bring them in line with what other countries pay, saving billions. By John Wilkerson and Daniel Payne STAT+ | Pharmaceutical industry evades drug price transparency, again For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs. By Bob Herman STAT+ | FDA flashpoints to watch next year Today's biotech news covers FDA flashpoints to watch next year, Cytokinetics finally lands its first FDA drug, and more. By Meghana Keshavan Adobe STAT+ | A seasoned biotech VC looks to 2026 and sees a wave of IPOs coming Atlas Venture's Bruce Booth believes more drugmakers are ready to access public markets in the coming year. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser